EJ. Mroszczak, R. Runkel; LJ. Strand; RV. Tomlinson; A. Fratis; E. Segre, Cloprednol bioavailability in humans., in J Pharm Sci, vol. 67, n. 7, luglio 1978, pp. 920-3, PMID 660508.
H. Möllmann, G. Hochhaus; S. Rohatagi; J. Barth; H. Derendorf; M. Krieg; H. Weisser; AC. Möllmann, Pharmacokinetics and pharmacodynamics of cloprednol., in Int J Clin Pharmacol Ther, vol. 34, n. 1, gennaio 1996, pp. 1-5, PMID 8688990.
UF. Legler, Pharmacokinetics of cloprednol in healthy volunteers., in Int J Clin Pharmacol Ther Toxicol, vol. 26, n. 4, aprile 1988, pp. 173-5, PMID 3403094.
DH. Goodman, Comparative study of cloprednol versus placebo in asthma., in Ann Allergy, vol. 40, n. 6, giugno 1978, pp. 376-80, PMID 352197.
R. Ellul-Micallef, FF. Fenech; D. Parrott, Comparison of cloprednol and prednisolone in chronic asthmatic patients., in Br J Clin Pharmacol, vol. 6, n. 1, luglio 1978, pp. 91-3, PMID 352380.
UD. Gavani, JS. Hyde; S. Khurana; LM. Manaligod, Long-term cloprednol use in chronic asthma., in JAMA, vol. 242, n. 24, dicembre 1979, pp. 2679-82, PMID 501863.
Miskovits G, Rado JP, Toth A, Zolnay E, Efficacy, safety and hypothalamic-pituitary-adrenal axis function in patients with asthma treated with cloprednol, in Respiration, vol. 38, n. 6, 1979, pp. 345–52, PMID 231809.
TC. Medici, P. Rüegsegger, Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study., in Clin Pharmacol Ther, vol. 48, n. 4, ottobre 1990, pp. 455-66, PMID 2225706.
E. Ortega, C. Rodriguez; LJ. Strand; E. Segre, Effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal axis function., in J Int Med Res, vol. 4, n. 5, 1976, pp. 326-37, PMID 1028634.